We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer
Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer
January 28, 2013
Active Biotech announced the initial results from the ANYARA Phase II/III clinical study. 4-Traders
